journal article·2021-01-13

Integrating Epigenetic Modulators in Nanofibers for Synergistic Gastric Cancer Therapy via Epigenetic Reprogramming

Lirui Wang, Chunlei Zhang, Yuping Hong, Xinhong Li, Tangan Li, Ang Gao, Shaojun Pan, Bin Liu, Han Jin, Daxiang Cui

Nano Letters· Volume 21· Issue 1
Publisher page

Abstract

Epigenetic dysregulations resulting from the defects of epigenetic regulators are often reversible in tumorigenesis, making them promising cancer therapeutic targets. However, the limited specificity of action, short-term stability, and low retention of the epigenetic drugs greatly impede their clinical efficacy against solid tumors. Herein a method of combinatorial delivery of epigenetic modulatory drugs via a molecular self-assembly strategy was developed using inhibitors of DNA methyltransferases and histone deacetylases. The drug–drug conjugates can self-assemble into nanofibers with enhanced chemical stability. The nanofibers synergistically regulate aberrant DNA methylation and histone deacetylation, subsequently reprogram the gene expression profiles, and finally inhibit gastric cancer cell proliferation and promote cell apoptosis. The superior in vivo therapeutic efficacy of the nanofibers could be ascribed to the prolonged retention and accumulation in tumors and the minimized off-target effects. Therefore, this design of epigenetic-drug-based nanofiber formulation may provide a valuable paradigm for cancer therapy through epigenetic reprogramming.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Histone Deacetylase Inhibitors Research · Epigenetics and DNA Methylation · MXene and MAX Phase Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Centre for Intelligent Diagnosis and Treatment Instrument, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China

Shanghai Key Lab of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, P. R. China

School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, P. R. China

National Engineering Center for Nanotechnology, Collaborative Innovational Center for System Biology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China

Funding

National Natural Science Foundation of China

References (41)

Show source-provided references
1. 10.1101/gad.178760910.1101/gad.1787609 ↗
2. 10.7326/0003-4819-134-7-200104030-0001110.7326/0003-4819-134-7-200104030-00011 ↗
3. 10.1200/JCO.2004.07.15110.1200/JCO.2004.07.151 ↗
4. 10.1038/ncponc123810.1038/ncponc1238 ↗
5. 10.1111/j.1749-6632.2003.tb05977.x10.1111/j.1749-6632.2003.tb05977.x ↗
6. 10.1007/978-3-030-22254-3_1410.1007/978-3-030-22254-3_14 ↗
7. 10.1007/s12272-019-01126-z10.1007/s12272-019-01126-z ↗
8. 10.1093/jnci/dji31110.1093/jnci/dji311 ↗
9. 10.3390/molecules2003389810.3390/molecules20033898 ↗
10. 10.1038/504710.1038/5047 ↗
11. 10.1038/s41375-018-0293-810.1038/s41375-018-0293-8 ↗
12. 10.4155/fmc.12.310.4155/fmc.12.3 ↗
13. 10.1200/JCO.2005.07.45010.1200/JCO.2005.07.450 ↗
14. 10.1021/acs.nanolett.0c0004710.1021/acs.nanolett.0c00047 ↗
15. 10.1021/acs.nanolett.0c0114010.1021/acs.nanolett.0c01140 ↗
16. 10.1016/j.biomaterials.2019.11960610.1016/j.biomaterials.2019.119606 ↗
17. 10.1021/jacs.8b0939610.1021/jacs.8b09396 ↗
18. 10.1021/acsnano.0c0644610.1021/acsnano.0c06446 ↗
19. 10.1039/C9NR07334E10.1039/C9NR07334E ↗
20. 10.1517/13543784.16.7.111110.1517/13543784.16.7.1111 ↗
21. 10.1073/pnas.95.6.300310.1073/pnas.95.6.3003 ↗
22. 10.1002/cbic.20140218810.1002/cbic.201402188 ↗
23. 10.1016/j.jinorgbio.2011.03.00310.1016/j.jinorgbio.2011.03.003 ↗
24. 10.1002/ejic.20060075810.1002/ejic.200600758 ↗
25. 10.1021/jo070739s10.1021/jo070739s ↗
26. Zhou Z. · Asian J. Chem. · 2012 · 24 · 964
27. Suzuki H. · Asian Pac. J. Cancer. Prev. · 2006 · 7 · 177
28. 10.1046/j.1440-1746.2001.02554.x10.1046/j.1440-1746.2001.02554.x ↗
29. 10.1111/j.1600-0463.2005.apm_04.x10.1111/j.1600-0463.2005.apm_04.x ↗
30. 10.18632/oncotarget.1462810.18632/oncotarget.14628 ↗
31. 10.1158/1535-7163.MCT-07-001010.1158/1535-7163.MCT-07-0010 ↗
32. 10.1186/s13148-016-0213-610.1186/s13148-016-0213-6 ↗
33. 10.1016/j.yexcr.2018.07.01710.1016/j.yexcr.2018.07.017 ↗
34. 10.1016/0092-8674(92)90561-P10.1016/0092-8674(92)90561-P ↗
35. 10.2217/epi.15.11410.2217/epi.15.114 ↗
36. 10.1038/nprot.2016.09510.1038/nprot.2016.095 ↗
37. 10.1126/science.281.5381.131210.1126/science.281.5381.1312 ↗
38. Waldman T. · Cancer Res. · 1995 · 55 · 5187
39. 10.1038/nm0697-61410.1038/nm0697-614 ↗
40. Aaltomaa S. · Anticancer Res. · 1993 · 13 · 533
41. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗